Rianlon Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Rianlon heeft een totaal eigen vermogen van CN¥4.6B en een totale schuld van CN¥2.7B, wat de schuld-eigenvermogensverhouding op 57.8% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥8.9B en CN¥4.3B. De EBIT Rianlon is CN¥461.2M waardoor de rentedekking 11.8 is. Het heeft contanten en kortetermijnbeleggingen van CN¥1.2B.

Belangrijke informatie

57.8%

Verhouding schuld/eigen vermogen

CN¥2.68b

Schuld

Rente dekkingsratio	11.8x
Contant	CN¥1.15b
Aandelen	CN¥4.63b
Totaal verplichtingen	CN¥4.28b
Totaal activa	CN¥8.91b

Recente financiële gezondheidsupdates

Does Rianlon (SZSE:300596) Have A Healthy Balance Sheet?

Mar 25

Recent updates

Rianlon's (SZSE:300596) Profits May Not Reveal Underlying Issues

Nov 04

Even With A 40% Surge, Cautious Investors Are Not Rewarding Rianlon Corporation's (SZSE:300596) Performance Completely

Oct 08

Rianlon (SZSE:300596) May Have Issues Allocating Its Capital

Sep 26

Rianlon's (SZSE:300596) Dividend Will Be CN¥0.344

Jun 27

Investors Still Aren't Entirely Convinced By Rianlon Corporation's (SZSE:300596) Earnings Despite 33% Price Jump

Apr 29

Rianlon Corporation Just Missed EPS By 7.9%: Here's What Analysts Think Will Happen Next

Apr 21

Does Rianlon (SZSE:300596) Have A Healthy Balance Sheet?

Mar 25

There's No Escaping Rianlon Corporation's (SZSE:300596) Muted Earnings Despite A 26% Share Price Rise

Mar 06

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥4.1B ) 300596 } overtreffen de korte termijn passiva ( CN¥2.7B ).

Langlopende schulden: De kortetermijnactiva 300596 ( CN¥4.1B ) overtreffen de langetermijnschulden ( CN¥1.6B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 32.9% ) 300596 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 300596 is de afgelopen 5 jaar gestegen van 36.9% naar 57.8%.

Schuldendekking: De schuld van 300596 wordt niet goed gedekt door de operationele kasstroom ( 13% ).

Rentedekking: De rentebetalingen op de schuld van 300596 worden goed gedekt door EBIT ( 11.8 x dekking).

Rianlon Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Rianlon (SZSE:300596) Have A Healthy Balance Sheet?

Recent updates

Rianlon's (SZSE:300596) Profits May Not Reveal Underlying Issues

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 16%

Even With A 40% Surge, Cautious Investors Are Not Rewarding Rianlon Corporation's (SZSE:300596) Performance Completely

New minor risk - Share price stability

Rianlon Corporation to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 20%

Rianlon (SZSE:300596) May Have Issues Allocating Its Capital

Price target decreased by 7.6% to CN¥35.69

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Rianlon Corporation to Report First Half, 2024 Results on Aug 26, 2024

Rianlon's (SZSE:300596) Dividend Will Be CN¥0.344

Dividend of CN¥0.34 announced

Rianlon Corporation Announces Final Dividend of A Shares for 2023, Payable on July 2, 2024

Investors Still Aren't Entirely Convinced By Rianlon Corporation's (SZSE:300596) Earnings Despite 33% Price Jump

First quarter 2024 earnings released: EPS: CN¥0.47 (vs CN¥0.36 in 1Q 2023)

Investor sentiment improves as stock rises 19%

Rianlon Corporation Just Missed EPS By 7.9%: Here's What Analysts Think Will Happen Next

Rianlon Corporation, Annual General Meeting, May 13, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Rianlon Corporation to Report Q1, 2024 Results on Apr 27, 2024

Does Rianlon (SZSE:300596) Have A Healthy Balance Sheet?

There's No Escaping Rianlon Corporation's (SZSE:300596) Muted Earnings Despite A 26% Share Price Rise

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 15%

Rianlon Corporation to Report Fiscal Year 2023 Results on Apr 18, 2024

Price target decreased by 7.6% to CN¥41.20

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Rianlon Corporation to Report Q3, 2023 Results on Oct 24, 2023

Less than half of directors are independent

Consensus revenue estimates fall by 14%

Price target decreased by 11% to CN¥49.57

New minor risk - Profit margin trend

Price target decreased by 9.7% to CN¥55.60

Rianlon Corporation to Report First Half, 2023 Results on Aug 25, 2023

Rianlon Corporation Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 21, 2023

Price target decreased by 8.3% to CN¥68.67

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥80.25

Price target increased to CN¥80.25

Third quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.55 in 3Q 2021)

Price target increased to CN¥73.64

Second quarter 2022 earnings released: EPS: CN¥0.70 (vs CN¥0.47 in 2Q 2021)

Rianlon Corporation Approves Management Appointments

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Rianlon Corporation Announces the Implementation of Final Cash Dividend for 2021, Payable on 14 April 2022

Price target increased to CN¥51.00

Rianlon Corporation, Annual General Meeting, Mar 21, 2022

Rianlon Corporation Proposes Cash Dividend for the Year 2021

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.55 (vs CN¥0.38 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.47 (vs CN¥0.35 in 2Q 2020)

Rianlon Corporation Announces Implementation Final Cash Dividend for the Year 2020, Payable on 21 May 2021

First quarter 2021 earnings released: EPS CN¥0.44 (vs CN¥0.31 in 1Q 2020)

Investor sentiment improved over the past week

Rianlon Corporation, Annual General Meeting, Mar 30, 2021

Full year 2020 earnings released: EPS CN¥1.43 (vs CN¥1.38 in FY 2019)

Revenue beats expectations, earnings disappoint

New 90-day low: CN¥33.65

Rianlon Corporation to Report Fiscal Year 2020 Results on Mar 09, 2021

Price target raised to CN¥43.32

New 90-day high: CN¥39.29

Price target lowered to CN¥38.25

Third quarter earnings released

Rianlon Corporation to Report Q3, 2020 Results on Oct 20, 2020

Rianlon Corporation announced that it expects to receive CNY 1 billion in funding

New 90-day low - CN¥31.30

Earnings released

New 90-day high - CN¥37.30

Rianlon Corporation to Report First Half, 2020 Results on Aug 25, 2020

Analyse van de financiële positie